Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients With Aortic Stenosis

التفاصيل البيبلوغرافية
العنوان: Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients With Aortic Stenosis
المؤلفون: Anders M. Greve, Emilie Ramberg, Olav W. Nielsen, Ronnie Willenheimer, Steen B. Haugaard, Ahmad Sajadieh, Kristian Wachtell, Michael H. Olsen, Ronan M. G. Berg
المصدر: Ramberg, E, Greve, A M, Berg, R M G, Sajadieh, A, Haugaard, S B, Willenheimer, R, Olsen, M H, Wachtell, K & Nielsen, O W 2021, ' Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients With Aortic Stenosis ', American Journal of Cardiology, vol. 141, pp. 93-97 . https://doi.org/10.1016/j.amjcard.2020.11.015Test
سنة النشر: 2021
مصطلحات موضوعية: Male, medicine.medical_specialty, Ezetimibe, Simvastatin Drug Combination, 030204 cardiovascular system & hematology, Placebo, Asymptomatic, 03 medical and health sciences, 0302 clinical medicine, Ezetimibe, Cause of Death, Internal medicine, Natriuretic Peptide, Brain, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Mortality, Aged, Proportional Hazards Models, Cause of death, Hypernatremia, business.industry, Anticholesteremic Agents, Incidence, nutritional and metabolic diseases, Aortic Valve Stenosis, Middle Aged, medicine.disease, Peptide Fragments, Stenosis, Simvastatin, Cardiology, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, Hyponatremia, business, medicine.drug
الوصف: Asymptomatic aortic stenosis (AS) is a frequent condition that may cause hyponatremia due to neurohumoral activation. We examined if hyponatremia heralds poor prognosis in patients with asymptomatic AS, and whether AS in itself is associated with increased risk of hyponatremia. The study question was investigated in 1,677 individuals that had and annual plasma sodium measurements in the SEAS (Simvastatin and Ezetimibe in AS) trial; 1,873 asymptomatic patients with mild-moderate AS (maximal transaortic velocity 2.5 to 4.0 m/s) randomized to simvastatin/ezetimibe combination versus placebo. All-cause mortality was the primary endpoint and incident hyponatremia (P-Na+
اللغة: English
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03dfea2663a3c4879ea1d83baf1970a5Test
https://portal.findresearcher.sdu.dk/da/publications/7f6c8803-df05-4ea3-a983-1bf914f6fe46Test
حقوق: CLOSED
رقم الانضمام: edsair.doi.dedup.....03dfea2663a3c4879ea1d83baf1970a5
قاعدة البيانات: OpenAIRE